![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sofosbuvir Plus Ribavirin, an Interferon-Free Regimen, in the Treatment of Egyptian Patients With Chronic Genotype 4 HCV Infection
|
|
|
Reported by Jules Levin
APASL 2015, March 12-15, Istanbul
Gamal Shiha1, Gamal Esmat2, Mohamed Hassany3, Rabab Fouad2, Waleed Samir1, Radi Hammad3, Marwa Khairy2, Reham Soliman1, Benedetta Massetto4, Steven J. Knox4, Kathryn Kersey4, Deyuan Jiang4, Brian Doehle4, Diana M. Brainard4, John G. McHutchison4, Wahid Doss3
1Egyptian Liver Research Institute and Hospital (ELRIAH) and Mansoura University, Mansoura, Egypt; 2Cairo University, Cairo, Egypt; 3National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; 4Gilead Sciences, Inc., Foster City, CA, USA
![CROI1.gif](../images/032715/032715-17/CROI1.gif)
![CROI2.gif](../images/032715/032715-17/CROI2.gif)
![CROI3.gif](../images/032715/032715-17/CROI3.gif)
![CROI4.gif](../images/032715/032715-17/CROI4.gif)
![CROI5.gif](../images/032715/032715-17/CROI5.gif)
![CROI6.gif](../images/032715/032715-17/CROI6.gif)
![CROI7.gif](../images/032715/032715-17/CROI7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|